Cargando…
Erythropoietin ameliorates diabetes-associated cognitive dysfunction in vitro and in vivo
Several studies indicate that erythropoietin (EPO) has remarkable neuroprotective effects in various central nervous system disorders, while little is known about the effects of EPO in diabetes-associated cognitive dysfunction. Therefore, the present study aimed to investigate whether EPO ameliorate...
Autores principales: | Wang, Meng, Yan, Wenhui, Liu, Yuan, Hu, Hao, Sun, Qiang, Chen, Xinlin, Zang, Weijin, Chen, Lina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459814/ https://www.ncbi.nlm.nih.gov/pubmed/28584284 http://dx.doi.org/10.1038/s41598-017-03137-6 |
Ejemplares similares
-
Erythropoietin ameliorates hyperglycemia in type 1-like diabetic rats
por: Niu, Ho-Shan, et al.
Publicado: (2016) -
Recombinant human erythropoietin ameliorates cognitive dysfunction of APP/PS1 mice by attenuating neuron apoptosis via HSP90β
por: Wan, Hua-Li, et al.
Publicado: (2022) -
Erythropoietin Mitigates Diabetic Nephropathy by Restoring PINK1/Parkin-Mediated Mitophagy
por: Yi, Xinyao, et al.
Publicado: (2022) -
Neuritin inhibits astrogliosis to ameliorate diabetic cognitive dysfunction
por: Zhang, Zuo, et al.
Publicado: (2021) -
Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
por: Yin, Qingqing, et al.
Publicado: (2020)